| Pfizer AG - Edronax, Tabletten 4 mg | | 54159 | | 02 | | Edronax, Tabletten 4 mg | | | | N06AX18 | | Reboxetin | | 07.12.2000 | | |
| | Composition | | reboxetinum 4 mg ut reboxetini mesilas, cellulosum microcristallinum, calcii hydrogenophosphas dihydricus, crospovidonum, silica colloidalis hydrica, magnesii stearas, pro compresso. | | Packungsbestandteile | | Principe actif | Concentr. |
|---|
| Reboxetine | 4 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Reboxetine | 4 mg |
| | Agents auxilliaires |
|---|
| Calcium Hydrogenophosphate Dihydrate | | Cellulosum Microcristallinum | | Crospovidonum | | Magnesii Stearas | | Pro Compresso | | Silica Colloidalis Hydrica |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 013 | 30 Comprimé(s) | 17.06 | 34.95 | B | LS | Non | | 021 | 100 Comprimé(s) | 51.26 | 72.15 | B | LS | Non |
|
|
